NYU Langone Health Perlmutter Cancer Center - Manhattan — Manhattan, New York

NYU Langone Health Perlmutter Cancer Center - Manhattan is a clinical research site located in Manhattan, New York, United States 10016.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

NYU Langone Health Perlmutter Cancer Center - Manhattan has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Large B-cell Lymphoma (LBCL).

Sponsors: NYU Langone Health.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Manhattan

Browse all research sites in New York · View every site in Manhattan

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health Perlmutter Cancer Center - Manhattan?

NYU Langone Health Perlmutter Cancer Center - Manhattan has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health Perlmutter Cancer Center - Manhattan conducted?

NYU Langone Health Perlmutter Cancer Center - Manhattan has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Large B-cell Lymphoma (LBCL).

Is NYU Langone Health Perlmutter Cancer Center - Manhattan accredited by Crixeo Clinical Trials?

NYU Langone Health Perlmutter Cancer Center - Manhattan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health Perlmutter Cancer Center - Manhattan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.